A
301408
vs
S
Shanghai Composite
Over the past 12 months, Anhui Huaren Health Pharmaceutical Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +46% compared to the Shanghai Composite's +23% growth.
Stocks Performance
301408 vs Shanghai Composite
Performance Gap
301408 vs Shanghai Composite
Performance By Year
301408 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Anhui Huaren Health Pharmaceutical Co Ltd
Glance View
Anhui Huaren Health Pharmaceutical Co., Ltd. engages in pharmaceutical distribution. The company is headquartered in Hefei, Anhui and currently employs 5,785 full-time employees. The company went IPO on 2023-03-01. The pharmaceutical retail business is mainly engaged in the sales of medicines, health food and medical equipment, as well as the diagnosis and treatment of common diseases. The agency business mainly promotes and sells to downstream pharmaceutical retail enterprises. The terminal centralized procurement business mainly provides one-stop distribution services for individual pharmacies and small chain retail terminals.
